Spokane: Meningococcal meningitis case reported in Sacajawea Central School student



[ad_1]

Spokane County health officials report on a case Neisseria meningitidis, also known as meningococcal disease or meningitis, is a female student in a hospital who attends Sacajawea Central School.

    Grain Neisseria meningitidis diplococcal bacteria / CDC
Grain Neisseria meningitidis diplococcal bacteria / CDC

“We don't want to see any of our students or families go through something like this. We continue to keep these students and her family in hearts and thoughts, ”said Brian Coddington, Spokane community relations director (SPS). “We also know that this news can cause discontent among other students and families and is easy to understand. We want to reiterate that other issues have not been identified and that there is a very low risk of illness in others. "

Calls were already sent by email to Sacajawea families and staff containing information about the disease.

“Public health has also been in touch with families and close links with students as part of their scrutiny. As well as ensuring that they are aware of the very low risks of getting ill, we also check that they are up to date with their vaccination information, ”said Dr Bob Lutz, t SRHD health officer. “If there was a close link – where saliva sprouts could be shared – we recommend that these people look for meningitis symptoms and signs and contact their healthcare provider with questions or concerns. ”

No other issues were identified and the risk that the infection is reaching others is very low.

Meningococcal disease is a infectious disease that can be very serious. It can lead to an infection in cover of the backbone, bacteria in the blood or a gig. It is widely dispersed, as if living on the condition or kissing. Outbreaks of disease are usually seen in communities, schools, colleges and other high risk figures.

The symptoms of meningitis are included, but there is no limit to fever, fever, headache, fat, upset and sometimes a rash. Rapid medical attention is important if there is a suspected meningococcal disease. People with concerns should contact their healthcare provider.

Disease control centers recommend the vaccine with combined meningococcal vaccine for every teenager and teenager aged 11 to 12 years, with a booster dose at 16 years of age. The vaccines and young adults (16 through 23 years) can be immunized with a meningococcal serogroup B. vaccine.

Related:

[ad_2]
Source link